⚠️ Personal research and trading journal — not investment advice. The author does not provide licensed advisory services.
When a stock gets flagged by IBD as an actionable buy at a fresh breakout, what happens next?
I tested this on 77 cases where IBD described a stock as both ACTIONABLE_BUY and in a fresh breakout pattern — cup with handle, VCP, flat base — over the period 2019-2026. I tracked two things: the maximum run-up within the next 120 trading days (the best the stock did from the entry), and the actual return at 120 days (where the stock ended up).
The results explain why discipline around when to sell matters as much as knowing when to buy.
The Run-Up Is Real
The maximum run-up for IBD actionable buy + fresh breakout mentions is substantial:
- Mean max run-up: +23.2% (average of the best price each stock hit after mention)
- Median max run-up: +14.6%
- 91% of mentions showed a positive max run-up
When IBD identifies a fresh breakout with an actionable buy context, the stock usually does move higher. Not always dramatically, but 91% of cases saw some positive price movement from the entry point. This isn't noise — it's a real signal that something is happening in these stocks.
The run-up to at least 20%: 36% of cases versus 22.5% for a random comparable sample. That's a +13.5 percentage-point lift — roughly 60% better odds of a 20%+ move than baseline.
The 120-Day Return Destroys the Picture
Now the harder number: where did these stocks end up at 120 trading days (roughly six months after the IBD mention)?
- Mean return at t+120d: negative
- Two extreme examples: UNH (United Health) fell −49% from its mention price by day 120. SMCI (Super Micro Computer) fell −45%.
The stocks that had run up sharply came back down. The average gain, measured at any fixed future date, collapsed. The distribution has a long left tail of stocks that reversed hard, dragging the mean into negative territory.
This isn't just two bad examples. The pattern holds in aggregate: the t+120d return distribution is much worse than the max run-up distribution suggests. There's a systematic gap between "how high the stock went" and "what it was worth six months after you bought."
The Hold-and-Pray Problem
The mechanism is what traders call "extended and vulnerable." A stock that has just broken out is in the most optimistic phase of its move. Momentum is in your favor. Volume confirmed the break.
But breakout stocks are also trading at the highest price they've been in weeks or months. The stocks that have the most dramatic initial runs are also the most sensitive to any change in sentiment — an earnings miss, a sector rotation, a broader market correction.
If you hold through the peak and into the reversal, you give back most of what the stock gave you. The mean t+120d return being negative means that on average, if you bought at the breakout and held passively for six months, you ended up losing money — even though 91% of those stocks showed a higher price at some point during your hold.
This is what "hold-and-pray" does: it converts a high win-rate signal into a breakeven-or-negative outcome, because you hold through the peaks without a systematic exit plan.
What the 2R Partial-TP Does
The partial take-profit (partial-TP) rule I use: when a stock reaches 2× my initial risk from entry, sell approximately half the position. Leave the rest to run.
Why 2R specifically? The median max run-up of +14.6% combined with a typical stop of 5-7% means a 2R move (+10-14%) captures the median expected gain from these mentions. By selling half at 2R, I'm systematically extracting value from the part of the distribution that reliably exists.
Compared to the 120-day passive hold: - Passive hold: mean return approaches negative due to left-tail reversals - 2R partial exit: locks in the gain on half the position before the reversal, then trails the remaining half
The remaining half can benefit from the 36% of cases that hit 20%+ (the right tail). But the partial exit ensures the position is already profitable before the reversal risk materializes.
The Timing Implication
There's also a timing insight here. The 36% that hit ≥20% gains did so at some point within 120 days — not necessarily near the end. Stocks that break out strongly often peak within 30-60 days of the breakout, then consolidate or reverse.
This means the "right" exit for a breakout trade is often in the first two months, not the sixth. A mechanical trailing stop using a short-term moving average (21-day EMA, in the system I use) tends to exit around the right time — when the momentum starts fading.
The t+120d passive return being negative confirms that waiting for a clear "the top is in" signal is usually too late. By then, 30-40% of the gain is already gone.
What This Changes
Hold the position in stages: - At 2R gain: sell ~50% of the position. This converts a speculative position into a funded trade. - Use a rising EMA (21-day) as the trailing stop for the remaining shares. Exit on close below the EMA after the stock has already had a meaningful move. - Don't set a specific price target for the second half. Let the market structure determine when momentum is done.
Don't extend holds mechanically: - A 6-month hold rule ("let it ride all summer") sounds patient and disciplined. For IBD breakout stocks, the data says it costs you. These stocks move fast in both directions.
The 36% that hit 20%+ are worth staying for: - Don't exit the entire position at 2R. The right tail is real — ARM, JBL, NVDA in their runs had much larger moves than 14%. Half-out at 2R lets you participate in the right-tail cases while protecting the gain.
Track. Study. Wait. Strike.
Personal research and trading journal — not investment advice. The author does not provide licensed advisory services. — MOEasymmetry
Draft 2026-06-12. Source: 77 IBD mentions tagged ACTIONABLE_BUY + PATTERN_BREAKOUT_FRESH (fresh base, not extended), 2019-2026. Max run-up = highest close from entry over next 120 trading days. t+120d return = close at day 120 vs entry. Examples UNH and SMCI included as the largest adverse cases in sample, not cherry-picked as typical.